KaydedilenlerDerginizi ekleyin

Dergiler / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2026 / Volume: 8 Issue: 1

Kurkumin HEK-293 Hücre Hattında Metotreksat Kaynaklı Hücresel Hasarı Düzenledi

Curcumin Regulated of Methotrexate-Induced Cell Damage in HEK-293 Cell Line

Betül Yazğan(KASTAMONU ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-4029-2007
Sayfa
—
Yayın Tarihi
2021-03-31
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bu sonuçlar, KUR uygulamasının MTX kaynaklı hücresel stres ve toksisiteyi, antioksidan mekanizmalarla düzenleyerek, MTX kemoterapisine etkili bir yardımcı ajan olabileceğini göstermektedir.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Klasik bir antifolat olan metotreksat (MTX), çeşitli kanserlerin tedavisinde yaygın olarak kullanılan ve yan etkilerinden dolayı üzerinde çalışılan antikanser ajanlardan biridir.
📊
Temel Bulgular & Veri:Ne yazık ki, MTX'in hücre üzerine toksik etkisi, sadece tümör hücreleri ile sınırlı olmayıp diğer hayati organları da etkilemektedir.
💡
Sonuç & Katkı:Bu sonuçlar, KUR uygulamasının MTX kaynaklı hücresel stres ve toksisiteyi, antioksidan mekanizmalarla düzenleyerek, MTX kemoterapisine etkili bir yardımcı ajan olabileceğini göstermektedir.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Curcumin · Glutathione peroxidase · Methotrexate

Özet

Klasik bir antifolat olan metotreksat (MTX), çeşitli kanserlerin tedavisinde yaygın olarak kullanılan ve yan etkilerinden dolayı üzerinde çalışılan antikanser ajanlardan biridir. Ne yazık ki, MTX'in hücre üzerine toksik etkisi, sadece tümör hücreleri ile sınırlı olmayıp diğer hayati organları da etkilemektedir. Bu durum MTX’in antikanser etkinliğini azaltmadan, hücresel toksik etkilerini azaltabilecek başka ajanlarla birlikte kullanımını zorunlu kılmaktadır. Antikanser ilaçların istenmeyen yan etkilerini azaltabilecek doğal antioksidanların kullanımıyla ilgili kapsamlı araştırmalar yapılmaktadır. Yapılan çalışmalarda, kurkuminin (KUR) çeşitli dokularda meydana gelen hücresel toksisite üzerindeki koruyucu etkileri, onun antioksidan, antienflamatuar ve antikanser etkilerinin olmasına atfedilebilir. Bu çalışma, MTX’in neden olduğu hücresel toksisitenin, KUR ile azaltılabileceği varsayılarak yapıldı. MTX’e maruz bırakılan insan embriyo böbrek (HEK-293) hücre serisinde, antioksidan bir ajan olan KUR’un düzenleyici rolü araştırıldı. HEK-293 hücreleri, Kontrol, KUR, MTX ve MTX+KUR olarak dört gruba ayrıldı. Kontrol grubundaki hücrelere herhangi bir uygulama yapılmadan, kültür ortamında 48 saat boyunca tutuldu. Diğer gruplardaki hücreler kültür ortamında 24 saat tutulduktan sonra, KUR grubundaki hücrelere 10 μM KUR, MTX grubundaki hücrelere 5 μM MTX ve MTX+KUR grubundaki hücrelere ise 5 μM MTX ve 10 μM KUR uygulandı. Uygulamaları takiben hücreler 24 saat boyunca kültür ortamında tutuldu. HEK-293 hücrelerindeki MTX kaynaklı lipit peroksidasyon (Lip-Px) aktivitesi Placer ve arkadaşlarının yöntemine göre, glutatyon (GSH) seviyeleri Sedlak ve Lindsay yöntemine göre ve glutatyon peroksidaz (GSH-Px) seviyeleri Lawrence ve Burk yöntemine göre spektrofotometrik (UV-1800) olarak ölçüldü. MTX ile inkübe edilen hücrelerde Lip-Px aktivitesinin arttığı, GSH ve GSH-Px aktivitelerinin ise önemli ölçüde azaldığı belirlenmiştir. KUR uygulamasının ise Lip-Px aktivitesini önemli ölçüde azaltırken, GSH ve GSH-Px aktivitelerini önemli ölçüde artmıştır. Bu sonuçlar, KUR uygulamasının MTX kaynaklı hücresel stres ve toksisiteyi, antioksidan mekanizmalarla düzenleyerek, MTX kemoterapisine etkili bir yardımcı ajan olabileceğini göstermektedir.

Abstract

Objective: Methotrexate (MTX), a conventional anti-folate, is an anti-cancer agent that is widely used for treatment of various types of cancers and it has been researched due to its side effects. Unfortunately, toxic effects of MTX is not limited just with tumour cells. It has also a toxic effect on healthy cells and organs. That is why it is an indispensability that MTX should be combined with other agents which can reduce the cellular toxicity of it at the same time not reducing its anti-cancer effectiveness. Exhaustive investigations have been performed to reveal the usage of natural antioxidants that can be reduce the unwanted side effects of anti-cancer drugs. It is postulated that Curcumin (CUR) has a protective effect on cellular toxicity in various types of cells due to its antioxidant, anti-inflammatory and anti-cancer effects. This study was designed presuming that cellular toxicity induced by MTX can be reduced by Curcumin. In this study the regulatory role of curcumin, an antioxidant agent, was investigated on MTX treated Human Embryonic Kidney Cell lines (HEK-293). Materials and Methods: HEK-293 cells were divided into four groups as Control, CUR, MTX and MTX+CUR. Cells in the control group were incubated in cell culture medium for 48 hours without any application. After the cells in the other groups were incubated in cell culture medium for 24 hours cells in CUR group was treated with 10 μM CUR, cells in MTX group treated with 5 μM MTX and cells in the MTX+CUR group were incubated with 5 μM MTX + 10 μM CUR. After the treatments, the cells were kept incubated 24 hours in cell culture medium. Results: MTX-induced lipid peroxidation (Lip-Px) activity (according to method of Placer et al.,), glutathione (GSH- according to Sedlak and Lindsay method) and glutathione peroxidase (GSH-Px - according to the Lawrence and Burk method) levels were measured spectrophotometrically (UV-1800) in HEK-293 cells. It has been determined that Lip-Px activity increased and GSH and GSH-Px activities decreased significantly in cells incubated with MTX. It is established that CUR treatment caused a significant decrease on the Lip-Px activity while causing a significant increment on GSH and GSH-Px activities. Conclusion: Consequently, these findings showed that curcumin (CUR) administration, triggering the antioxidant mechanisms, can be an effective adjuvant therapy for MTX chemotherapy by regulating MTX-induced cellular stress and toxicity.

🔖

Bu Makaleye Atıf Yap

Yazğan, B. (2021). Kurkumin HEK-293 Hücre Hattında Metotreksat Kaynaklı Hücresel Hasarı Düzenledi. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Volume: 8 Issue: 1. https://doi.org/10.34087/cbusbed.755807

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (90)

  1. Widemann BC, Adamson PC, Understanding and managing methotrexate nephrotoxicity. Oncol, 2006, 6, 694-703
  2. Noha ISS, Magda MN, Azza AS, Modulatory effect of curcumin against genotoxicity and oxidative stress induced by cisplatin and methotrexate in male mice, Food and Chemical Toxicology, 2017, 370-376
  3. Tousson E, Atteya E, El-Atrash E, Jeweely OI, Abrogation by Ginkgo Byloba leaf extract on hepatic and renal toxicity induced by methotrexate in rats, J Cancer Res Treat, 2014, 2(3), 44-51
  4. Santos MLC, de Brito BB, da Silva FAF, Botelho ACDS, de Melo FF, Nephrotoxicity in cancer treatment: An overview, World J Clin Oncol, 2020, 24, 11(4), 190-204
  5. Asvadi I, Hajipour B, Asvadi A, Asl N.A, Roshangar L, Khodadadi A, Protective effect of pentoxyfilline in renaltoxicity after methotrexate administration, European Reviewfor Medical and Pharmacological Sciences, 2011, 15, 1003–1009
  6. Farkhondeh T, Samarghandian S, Azimi-Nezhad M, Shahri AMP, Protective Effects of Curcumin Against Nephrotoxic Agents, Cardiovasc Hematol Disord Drug Targets, 2019, 19(3), 176-182
  7. Shi H, Hou C, Gu L, et al, Influence of pretreatment of piperazine ferulate on pharmacokinetic parameters of methotrexate in methotrexate-induced renal injury model rats by HPLC-MS, Asian J Pharm Sci, 2017, 12(2), 202-208
  8. El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA, Mechanisms of thymoquinone hepatorenal protection in methotrexateinduced toxicity in rats, Mediators Inflamm, 2015, 1-12
  9. Babiak R.M, Campello A.P, Carnieri E.G, Oliveira M.B, Methotrexate: pentose cycle and oxidative stress, CellBiochemistry and Function, 1998, 16, 283–293
  10. Mora L.D.O, Antunes L.M.G, Francescato H.D.C, Bianchi M.D.L.P, The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats, Pharmacol. Res, 2003, 47 (6), 517-522
  11. Daverey A, Agrawal SK, Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress, Brain Res, 2018, 1, 1692, 45-55
  12. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales N.P, Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives, Biol. Pharm. Bull, 2007, 30, 74-78
  13. Ebrahimifar M, Roudsari MH, Kazemi SM, Shahmabadi HE, Kanaani L, Alavi SA, Vasfi MI, Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells, Asian Pac J Cancer Prev, 2017, 18 (1), 65-68
  14. Aslanturk A, Uzunhisarcikli M, Protective potential of curcumin or taurine on nephrotoxicity caused by bisphenol A, Environmental Science and Pollution Research, 2020, doi: 10.1007/s11356-020-08716-1
  15. Palipoch S, Punsawad C, Chinnapun D, Suwannalert P, Amelioration of cisplatin-induced nephrotoxicity in rats by curcumin and a-tocopherol. Trop, J. Pharm. Res, 2014, 12(6), 973-979
  16. Huang C.F, Cui X.Q, Yang C.F, et al, Effects of curcumin on micronuclei formation and chromosome aberration induced by cyclophosphamide in mice, China J. Traditional Chin. Med, Pharm, 2011, 6, 42
  17. Sandur S.K, Pandey M.K, Sung B, et al, Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydro-curcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism, Carcinogenesis, 2007, 28, 1765-1773
  18. Vallianou N.G, Evangelopoulos A, Schizas N, Kazazis C, Potential Anticancer Properties and Mechanisms of Action of Curcumin, Anticancer Res, 2015, 35, 645–652
  19. Kunnumakkara A.B, Bordoloi D, Harsha C, et al, Curcumin mediates anticancer effects by modulating multiple cell signaling pathways, Clin. Sci, 2017, 131, 1781–1799
  20. Curcio M, Cirillo G, Tucci P, et al, Dextran-Curcumin Nanoparticles as a Methotrexate Delivery Vehicle: A Step Forward in Breast Cancer Combination Therapy, Pharmaceuticals (Basel) 2019, 25, 13(1):2
  21. Halliwell B, Oxidative stress and neurodegeneration: where are we now? J Neurochem, 2006, 97, 1634–1658
  22. Schieber M, Chandel NS, ROS Function in Redox Signaling and Oxidative Stress, Current Biology, 2014, 24(10), 453–462
  23. Eybl V, Kotyzova D, Koutensky J, Comparative study of natural antioxidants curcumin, resveratrol and melatonin in cadmium-induced oxidative damage in mice, Toxicology, 2006, 225, 150-156
  24. Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE, Selenium and brain function: a poorly recognized liaison, Brain Res Brain Res Rev, 2004 45, 164–178
  25. Legallicier B, Leclere C, Monteil C, et al, The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells, Drugs Exp Clin Res, 1996, 22(2), 41-50
  26. Biswas S.K, McClure D, Jimenez L.A, Megson I.L, Rahman I, Curcumin induces glutathione biosynthesis and inhibits NF-kB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity, Antioxidants redox Signal, 2005, 7(1-2), 32-41
  27. Hollborn M, Chen R, Wiedemann P, Cytotoxic effects of curcumin in human retinal pigment epithelial cells, PLoS One, 2013, 8:e59603
  28. Fayi MA, Otifi H, Alshyarba M, Dera AA, Rajagopalan P, Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFjB, KIM-1 and ameliorating Nrf2/HO-1 signalling, J Drug Target, 2020, 5;1-10
  29. Hu A, Huang JJ, Jin XJ, et al, Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway, Am J Cancer Res, 2015, 5(1), 278–288
  30. Iwona PC, Monika GG, Dorota NC, et al, Pioglitazone as a modulator of the chemoresistance of renal cell adenocarcinoma to methotrexate, Oncology Reports, 2020, 43(3), 1019-1030
  31. Placer ZA, Cushman L, Johnson BC, Estimation of products of lipid peroxidation (malonyl dialdehyde) in biological fluids, Analytical Biochem, 1966, 16, 359–364
  32. Sedlak J, Lindsay RHC, Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’ s reagent, Analytical Biochem, 1968, 25, 192–205
  33. Lawrence RA, Burk RF, Glutathione peroxidase activity in seleniumdeficient rat liver, Biochem Biophys Res Com, 1976, 71, 952–958
  34. Weijl N.I, Elsendoorn T.J, Lentjes E.G.W.M, et al, Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study, Eur. J. Cancer, 2004, 40 (11), 1713-1723
  35. Tian F, Fan, T, Zhang Y, Jiang Y, Zhang X, Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-kB signaling pathway in vitro and in vivo, Acta biochimica biophysica Sinica, 2012, 44 (10), 847-855
  36. Antunes LM, Araújo MC, Darin JD, Bianchi ML, Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells, Mutat Res, 2000, 16, 465(1-2), 131-7
  37. Corona-Rivera A, Urbina-Cano P, Bobadilla-Morales L, Protective in vivo effect of curcumin on copper genotoxicity evaluated by comet and micronucleus assays, J. Appl. Genet, 2007, 48 (4), 389-396
  38. Liu F, Ni W, Zhang J, et al, Administration of curcumin protects kidney tubules against renal ischemia-reperfusion injury (RIRI) by modulating nitric oxide (NO) signaling pathway, Cell Physiol Biochem, 2017, 44(1), 401–411
  39. Abarikwu SO, Durojaiye M, Alabi A, Asonye B, Akiri O, Curcumin protects against gallic acid-induced oxidative stress, suppression of glutathione antioxidant defenses, hepatic and renal damage in rats, Renal Failure, 2016, 38(2), 321–329
  40. Banji OJ, Banji D, Ch K, Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain, Food Chem Toxicol, 2014, 74, 51-9
  41. Surh Y.J, Chun K.S, Cancer chemopreventive effects of curcumin. In: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer US, 2007, 149-172
  42. Balasubramanayam M, Adaikala Koteswari A, Sampath Kumar R, Finny Monickaraj S, Uma Maheswari J, Mohan V, Kukumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications, J. Biosci, 2003, 28(6), 715-721
  43. Fiorillo C, Becatti M, Pensafini A, et al, Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kB, and JNK pathways, Free Radic. Biol. Med, 2008, 45, 839
  44. Sreejayan N, Rao M.N, Free radical scavenging activity of curcuminoids, Arzneim, 1996, 46(2), 169-171
  45. Lin X, Bai D, Wei Z, et al, Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway, PLoS One, 2019, 21, 14(5), e0216711. doi: 10.1371/journal.pone.0216711
  46. Widemann BC, Adamson PC, Understanding and managing methotrexate nephrotoxicity. Oncol, 2006, 6, 694-703
  47. Noha ISS, Magda MN, Azza AS, Modulatory effect of curcumin against genotoxicity and oxidative stress induced by cisplatin and methotrexate in male mice, Food and Chemical Toxicology, 2017, 370-376
  48. Tousson E, Atteya E, El-Atrash E, Jeweely OI, Abrogation by Ginkgo Byloba leaf extract on hepatic and renal toxicity induced by methotrexate in rats, J Cancer Res Treat, 2014, 2(3), 44-51
  49. Santos MLC, de Brito BB, da Silva FAF, Botelho ACDS, de Melo FF, Nephrotoxicity in cancer treatment: An overview, World J Clin Oncol, 2020, 24, 11(4), 190-204
  50. Asvadi I, Hajipour B, Asvadi A, Asl N.A, Roshangar L, Khodadadi A, Protective effect of pentoxyfilline in renaltoxicity after methotrexate administration, European Reviewfor Medical and Pharmacological Sciences, 2011, 15, 1003–1009
  51. Farkhondeh T, Samarghandian S, Azimi-Nezhad M, Shahri AMP, Protective Effects of Curcumin Against Nephrotoxic Agents, Cardiovasc Hematol Disord Drug Targets, 2019, 19(3), 176-182
  52. Shi H, Hou C, Gu L, et al, Influence of pretreatment of piperazine ferulate on pharmacokinetic parameters of methotrexate in methotrexate-induced renal injury model rats by HPLC-MS, Asian J Pharm Sci, 2017, 12(2), 202-208
  53. El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA, Mechanisms of thymoquinone hepatorenal protection in methotrexateinduced toxicity in rats, Mediators Inflamm, 2015, 1-12
  54. Babiak R.M, Campello A.P, Carnieri E.G, Oliveira M.B, Methotrexate: pentose cycle and oxidative stress, CellBiochemistry and Function, 1998, 16, 283–293
  55. Mora L.D.O, Antunes L.M.G, Francescato H.D.C, Bianchi M.D.L.P, The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats, Pharmacol. Res, 2003, 47 (6), 517-522
  56. Daverey A, Agrawal SK, Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress, Brain Res, 2018, 1, 1692, 45-55
  57. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales N.P, Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives, Biol. Pharm. Bull, 2007, 30, 74-78
  58. Ebrahimifar M, Roudsari MH, Kazemi SM, Shahmabadi HE, Kanaani L, Alavi SA, Vasfi MI, Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells, Asian Pac J Cancer Prev, 2017, 18 (1), 65-68
  59. Aslanturk A, Uzunhisarcikli M, Protective potential of curcumin or taurine on nephrotoxicity caused by bisphenol A, Environmental Science and Pollution Research, 2020, doi: 10.1007/s11356-020-08716-1
  60. Palipoch S, Punsawad C, Chinnapun D, Suwannalert P, Amelioration of cisplatin-induced nephrotoxicity in rats by curcumin and a-tocopherol. Trop, J. Pharm. Res, 2014, 12(6), 973-979
  61. Huang C.F, Cui X.Q, Yang C.F, et al, Effects of curcumin on micronuclei formation and chromosome aberration induced by cyclophosphamide in mice, China J. Traditional Chin. Med, Pharm, 2011, 6, 42
  62. Sandur S.K, Pandey M.K, Sung B, et al, Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydro-curcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism, Carcinogenesis, 2007, 28, 1765-1773
  63. Vallianou N.G, Evangelopoulos A, Schizas N, Kazazis C, Potential Anticancer Properties and Mechanisms of Action of Curcumin, Anticancer Res, 2015, 35, 645–652
  64. Kunnumakkara A.B, Bordoloi D, Harsha C, et al, Curcumin mediates anticancer effects by modulating multiple cell signaling pathways, Clin. Sci, 2017, 131, 1781–1799
  65. Curcio M, Cirillo G, Tucci P, et al, Dextran-Curcumin Nanoparticles as a Methotrexate Delivery Vehicle: A Step Forward in Breast Cancer Combination Therapy, Pharmaceuticals (Basel) 2019, 25, 13(1):2
  66. Halliwell B, Oxidative stress and neurodegeneration: where are we now? J Neurochem, 2006, 97, 1634–1658
  67. Schieber M, Chandel NS, ROS Function in Redox Signaling and Oxidative Stress, Current Biology, 2014, 24(10), 453–462
  68. Eybl V, Kotyzova D, Koutensky J, Comparative study of natural antioxidants curcumin, resveratrol and melatonin in cadmium-induced oxidative damage in mice, Toxicology, 2006, 225, 150-156
  69. Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE, Selenium and brain function: a poorly recognized liaison, Brain Res Brain Res Rev, 2004 45, 164–178
  70. Legallicier B, Leclere C, Monteil C, et al, The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells, Drugs Exp Clin Res, 1996, 22(2), 41-50
  71. Biswas S.K, McClure D, Jimenez L.A, Megson I.L, Rahman I, Curcumin induces glutathione biosynthesis and inhibits NF-kB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity, Antioxidants redox Signal, 2005, 7(1-2), 32-41
  72. Hollborn M, Chen R, Wiedemann P, Cytotoxic effects of curcumin in human retinal pigment epithelial cells, PLoS One, 2013, 8:e59603
  73. Fayi MA, Otifi H, Alshyarba M, Dera AA, Rajagopalan P, Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFjB, KIM-1 and ameliorating Nrf2/HO-1 signalling, J Drug Target, 2020, 5;1-10
  74. Hu A, Huang JJ, Jin XJ, et al, Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway, Am J Cancer Res, 2015, 5(1), 278–288
  75. Iwona PC, Monika GG, Dorota NC, et al, Pioglitazone as a modulator of the chemoresistance of renal cell adenocarcinoma to methotrexate, Oncology Reports, 2020, 43(3), 1019-1030
  76. Placer ZA, Cushman L, Johnson BC, Estimation of products of lipid peroxidation (malonyl dialdehyde) in biological fluids, Analytical Biochem, 1966, 16, 359–364
  77. Sedlak J, Lindsay RHC, Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’ s reagent, Analytical Biochem, 1968, 25, 192–205
  78. Lawrence RA, Burk RF, Glutathione peroxidase activity in seleniumdeficient rat liver, Biochem Biophys Res Com, 1976, 71, 952–958
  79. Weijl N.I, Elsendoorn T.J, Lentjes E.G.W.M, et al, Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study, Eur. J. Cancer, 2004, 40 (11), 1713-1723
  80. Tian F, Fan, T, Zhang Y, Jiang Y, Zhang X, Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-kB signaling pathway in vitro and in vivo, Acta biochimica biophysica Sinica, 2012, 44 (10), 847-855
  81. Antunes LM, Araújo MC, Darin JD, Bianchi ML, Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells, Mutat Res, 2000, 16, 465(1-2), 131-7
  82. Corona-Rivera A, Urbina-Cano P, Bobadilla-Morales L, Protective in vivo effect of curcumin on copper genotoxicity evaluated by comet and micronucleus assays, J. Appl. Genet, 2007, 48 (4), 389-396
  83. Liu F, Ni W, Zhang J, et al, Administration of curcumin protects kidney tubules against renal ischemia-reperfusion injury (RIRI) by modulating nitric oxide (NO) signaling pathway, Cell Physiol Biochem, 2017, 44(1), 401–411
  84. Abarikwu SO, Durojaiye M, Alabi A, Asonye B, Akiri O, Curcumin protects against gallic acid-induced oxidative stress, suppression of glutathione antioxidant defenses, hepatic and renal damage in rats, Renal Failure, 2016, 38(2), 321–329
  85. Banji OJ, Banji D, Ch K, Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain, Food Chem Toxicol, 2014, 74, 51-9
  86. Surh Y.J, Chun K.S, Cancer chemopreventive effects of curcumin. In: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer US, 2007, 149-172
  87. Balasubramanayam M, Adaikala Koteswari A, Sampath Kumar R, Finny Monickaraj S, Uma Maheswari J, Mohan V, Kukumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications, J. Biosci, 2003, 28(6), 715-721
  88. Fiorillo C, Becatti M, Pensafini A, et al, Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kB, and JNK pathways, Free Radic. Biol. Med, 2008, 45, 839
  89. Sreejayan N, Rao M.N, Free radical scavenging activity of curcuminoids, Arzneim, 1996, 46(2), 169-171
  90. Lin X, Bai D, Wei Z, et al, Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway, PLoS One, 2019, 21, 14(5), e0216711. doi: 10.1371/journal.pone.0216711.